학술논문
Differential effect of dabigatran, rivaroxiban and apixaban on thrombomodulin mediated activation of protein C and thrombin activated fibrinolysis inhibitor (TAFI) may impact their safety and efficacy profiles: FBL01
Document Type
Academic Journal
Author
Source
Journal of Thrombosis and Haemostasis. Jun 01, 2014 12 Suppl. 1:48-48
Subject
Language
English
ISSN
1538-7933